Aileron Therapeutics, Inc. (ALRN)
NASDAQ: ALRN · Real-Time Price · USD
2.760
-0.060 (-2.13%)
Nov 20, 2024, 4:00 PM EST - Market closed
Aileron Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for ALRN stock has a target of 19, which predicts an increase of 588.41% from the current stock price of 2.76.
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 18, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for ALRN is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $9 → $19 | Strong Buy | Maintains | $9 → $19 | +588.41% | Apr 18, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Hold → Strong Buy Upgrades $9 | Hold → Strong Buy | Upgrades | $9 | +226.09% | Dec 1, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $20 | Strong Buy | Maintains | $40 → $20 | +624.64% | Jun 30, 2022 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 29, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $40 | Strong Buy | Maintains | $60 → $40 | +1,349.28% | Jun 5, 2020 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.17
from -3.42
EPS Next Year
-1.82
from -2.17
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | n/a | n/a | n/a | |
| Avg | n/a | n/a | n/a | |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -2.24 | -1.87 | -1.77 | |
| Avg | -2.17 | -1.82 | -1.72 | |
| Low | -2.09 | -1.74 | -1.66 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.